Fitmox CV 625 Tablet is a combination antibiotic containing Amoxycillin 500mg and Clavulanic Acid 125mg, designed to combat a wide range of bacterial infections. Amoxycillin, a penicillin-class antibiotic, works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of susceptible bacteria. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Amoxycillin by preventing bacterial enzymes from breaking down the antibiotic, thereby overcoming resistance in beta-lactamase-producing bacteria. This synergistic action makes Fitmox CV 625 effective against infections caused by both gram-positive and gram-negative bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sinusitis. It is typically prescribed when monotherapy with Amoxycillin alone is insufficient due to resistant bacterial strains. The tablet should be taken orally, preferably with food to reduce gastrointestinal discomfort. Common side effects may include nausea, diarrhea, and mild allergic reactions; however, serious adverse effects are rare. Patients with a history of penicillin allergy should avoid this medication. Fitmox CV 625 should be used as directed by a healthcare professional to ensure optimal results and to minimize the risk of antibiotic resistance.